novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Eli Lilly and Nordisk are tackling heart health next A high dose of Wegovy

We don't have robust long-term data on: What happens to muscle mass and bone density over 5-10 years of use The impact on people who start these medications in their 20s or 30s Impact on fertility/reproductive outcomes Early data is showing that GLP-1 might help in PCOS, but what about long-term hormonal regulation

Its not worth risking your research on a compromised solution

And for the production of neurotransmitters and neuromodulators, things like dopamine and serotonin

They can recommend the best way to come off the medication

It usually takes several months to see the full effect, as you start on a low dose, which is titrated up monthly

Hegland, T